ForeSights: Salt Therapy – An old-fashioned, non-invasive treatment enjoying a renaissance as a new health and wellness solution

2017-09-08
Price :
Published : Sep-2017
No. of Pages : 23

ForeSights: Salt Therapy – An old-fashioned, non-invasive treatment enjoying a renaissance as a new health and wellness solution

Summary

Salt therapy is a non-invasive treatment that uses aerated salt or a salt bath to deliver health and wellness benefits. It comes in two forms: dry salt therapy (halotherapy) and wet salt therapy (flotation therapy). Both forms of salt therapy are claimed to promote relaxation and rejuvenation.

Salt therapy is an old-fashioned, drug-free treatment leveraging the claimed natural antibacterial and anti-inflammatory properties of salt that capitalizes on growing interest in complementary and alternative medicine.

Scope

- Dry salt therapy (halotherapy) takes mineral-rich salt and grinds it into a fine powder that is dispensed into the air to create an environment that mimics that of a salt cave.
- Inhaling salt is believed to provide respiratory benefits by thinning mucous which makes breathing easier. Aerated salt may also benefit the skin.
- Floatation therapy (wet salt therapy) involves floating in a small tank, tub, or pod filled with water and Epsom salt.
- Floatation therapy (also called float therapy) can provide a feeling of relaxation, pain relief, and stress relief – even inducing a meditative state in some cases.
- Dry salt therapy is believed to provide relief from respiratory ailments including asthma, sinusitis, bronchitis, and COPD. It may also help relieve chronic skin conditions like psoriasis and eczema.
- The economics of salt therapy are compelling, largely because labor and material costs are low. Salt therapy takes place in sessions that typically run around 45 minutes.

Reasons to buy

- Provides an early warning system for emerging trends, threats, and opportunities in fast-moving consumer goods.
- Drives analysis of potential future consumer behavior.
- Generates ideas and inspiration for new product development.

Filed in: Pharmaceutical, Pharmaceuticals and Healthcare
Publisher : GlobalData
More Reports
Title Price Buy Now

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – Venezuela

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Venezuela Summary Venezuela ranked 187 out of 190 countries in ease of doing business. In July 2017, rating firm Standard & Poor's downgraded Venezuela's economy to CCC with a negative outlook. Moody's also downgraded its rating to Caa3 with a negative outlook, while Fitch rated it at CCC with a negative outlook. Venezuela is one of the emerging pharmaceutical markets in South America, with a major dependence on imports. However, economic and political turmoil along with inefficient patent laws and drug pricing policies are major barriers. The value of the market was US$12.6 Billion in 2015, having increased from US$5.7 Billion in 2009, at a Compound Annual Growth Rate (CAGR) of 14.1%. Drug prices in Venezuela are ......
$1995

Hepatorenal Syndrome Global Clinical Trials Review, H2, 2017

Hepatorenal Syndrome Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, "Hepatorenal Syndrome Global Clinical Trials Review, H2, 2017" provides an overview of Hepatorenal Syndrome clinical trials scenario. This report provides top line data relating to the clinical trials on Hepatorenal Syndrome. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Cl......
$2500

Hemoglobinopathies Global Clinical Trials Review, H2, 2017

Hemoglobinopathies Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, "Hemoglobinopathies Global Clinical Trials Review, H2, 2017" provides an overview of Hemoglobinopathies clinical trials scenario. This report provides top line data relating to the clinical trials on Hemoglobinopathies. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical t......
$2500

Hepatic Injury Global Clinical Trials Review, H2, 2017

Hepatic Injury Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, "Hepatic Injury Global Clinical Trials Review, H2, 2017" provides an overview of Hepatic Injury clinical trials scenario. This report provides top line data relating to the clinical trials on Hepatic Injury. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. ......
$2500

Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency) Global Clinical Trials Review, H2, 2017

Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency) Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, "Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency) Global Clinical Trials Review, H2, 2017" provides an overview of Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency) clinical trials scenario. This report provides top line data relating to the clinical trials on Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type.......
$2500

Hemoglobinuria Global Clinical Trials Review, H2, 2017

Hemoglobinuria Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, "Hemoglobinuria Global Clinical Trials Review, H2, 2017" provides an overview of Hemoglobinuria clinical trials scenario. This report provides top line data relating to the clinical trials on Hemoglobinuria. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. ......
$2500

Liver Failure (Hepatic Insufficiency) Global Clinical Trials Review, H2, 2017

Liver Failure (Hepatic Insufficiency) Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, "Liver Failure (Hepatic Insufficiency) Global Clinical Trials Review, H2, 2017" provides an overview of Liver Failure (Hepatic Insufficiency) clinical trials scenario. This report provides top line data relating to the clinical trials on Liver Failure (Hepatic Insufficiency). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are ......
$2500

Hernia Global Clinical Trials Review, H2, 2017

Hernia Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, "Hernia Global Clinical Trials Review, H2, 2017" provides an overview of Hernia clinical trials scenario. This report provides top line data relating to the clinical trials on Hernia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated fro......
$2500

Hemophagocytic Lymphohistiocytosis Global Clinical Trials Review, H2, 2017

Hemophagocytic Lymphohistiocytosis Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, "Hemophagocytic Lymphohistiocytosis Global Clinical Trials Review, H2, 2017" provides an overview of Hemophagocytic Lymphohistiocytosis clinical trials scenario. This report provides top line data relating to the clinical trials on Hemophagocytic Lymphohistiocytosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated us......
$2500

Hepatic Veno Occlusive Disease Global Clinical Trials Review, H2, 2017

Hepatic Veno Occlusive Disease Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, "Hepatic Veno Occlusive Disease Global Clinical Trials Review, H2, 2017" provides an overview of Hepatic Veno Occlusive Disease clinical trials scenario. This report provides top line data relating to the clinical trials on Hepatic Veno Occlusive Disease. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's......
$2500